Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/143.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a free or cell-associated receptor.

Sub-classes under this class:

Class Number Class Name Patents
424/144.1 Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.) 615

Patents under this class:

Patent Number Title Of Patent Date Issued
8105591 Methods of antagonizing signal transduction in dorsal root ganglion cells Jan. 31, 2012
8105590 Methods of treating inflammation in neuronal tissue Jan. 31, 2012
8105589 Use of DR3 antibodies in the treatment of inflammatory disease Jan. 31, 2012
8101727 Compositions and methods of use for antibodies of c-Met Jan. 24, 2012
8101726 Ligands binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) that inhibit downstream uPAR interactions: identification and use in diagnosis or therapy Jan. 24, 2012
8101724 High-affinity human antibodies to human protease-activated receptor-2 Jan. 24, 2012
8101182 Methods and compositions for treating allergic diseases Jan. 24, 2012
8101180 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof Jan. 24, 2012
8097255 Mammalian receptor protein DCRS5; methods of treatment Jan. 17, 2012
8097254 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis Jan. 17, 2012
8097252 Methods and compositions for administering therapeutic and diagnostic agents Jan. 17, 2012
8092804 Binding members for interleukin-4 receptor alpha (IL-4R.alpha.)-173 Jan. 10, 2012
8092802 High affinity human antibodies to human IL-4 receptor Jan. 10, 2012
8092799 Antibodies to Apo-2 receptor polypeptides Jan. 10, 2012
8088383 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies Jan. 3, 2012
8088382 Methods of inhibiting transendothelial migration of neutrophils and monocytes with anti-CD99L2 antibodies Jan. 3, 2012
8088377 Human monoclonal antibodies against CD30 Jan. 3, 2012
8084028 Antibodies to VLA-1 Dec. 27, 2011
8084026 Multispecific binding molecules comprising connecting peptides Dec. 27, 2011
8084020 Use of anti-CD1 antibodies for the modulation of immune responses Dec. 27, 2011
8080248 Method of treating rheumatoid arthritis with an IL-6R antibody Dec. 20, 2011
8075892 Treatment with anti-ErbB2 antibodies Dec. 13, 2011
8075887 High affinity human antibodies to human IL-4 receptor Dec. 13, 2011
8071321 Methods for up-regulating antigen expression in tumors Dec. 6, 2011
8071097 Apoptotic anti-IgE antibodies Dec. 6, 2011
8071096 Anti-C5aR antibodies and uses thereof Dec. 6, 2011
8071093 Fully human anti-epidermal growth factor receptor antibodies Dec. 6, 2011
8067550 Hybridomas producing antibodies against non functional P2X7 receptor Nov. 29, 2011
8067001 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof Nov. 29, 2011
8067000 Cancer treatment with endothelin receptor antagonists Nov. 29, 2011
8063187 Methods and compositions for inhibiting CD32B expressing cells Nov. 22, 2011
8062634 Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor Nov. 22, 2011
8048415 Compositions and methods for promoting or inhibiting angiogenesis Nov. 1, 2011
8044180 Fc.gamma.RIIB specific antibodies and methods of use thereof Oct. 25, 2011
8043618 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment Oct. 25, 2011
8043617 Human antibodies to human IL-6 receptor Oct. 25, 2011
8039598 Met fab and SCFV fragments Oct. 18, 2011
8038996 Composition and method for cancer treatment Oct. 18, 2011
8038992 Target for regulating multiple sclerosis Oct. 18, 2011
8034904 Anti-IGF-I receptor antibody Oct. 11, 2011
8034352 Tetrameric cytokines with improved biological activity Oct. 11, 2011
8034344 Anti-IL-6/IL-6R antibodies and methods of use thereof Oct. 11, 2011
8034341 Methods of inhibiting tumor growth using blocking antibodies to IL-23R Oct. 11, 2011
8029794 Combining therapies targeting multiple toll-like receptors Oct. 4, 2011
8029793 Methods for inhibiting cell proliferation Oct. 4, 2011
8029783 DR5 antibodies and articles of manufacture containing same Oct. 4, 2011
8017113 Compositions and methods for diagnosing and treating an inflammation Sep. 13, 2011
8012485 Drug conjugate composition Sep. 6, 2011
8012481 Composition and method for inducing or restoring locomotor functions in an animal Sep. 6, 2011
8012473 C3b antibodies and methods for the prevention and treatment of complement-associated disorders Sep. 6, 2011

  Recently Added Patents
Catalyst composition comprising shuttling agent for ethylene multi-block copolymer formation
Optical fixing device and image forming apparatus
Connector with shielding device and method for manufacturing connector
Asynchronous task execution
Etching apparatus and methods
Systems and methods for updating a data store using a transaction store
Communication device and two-dimensional communication system using the same
  Randomly Featured Patents
New compositions containing taxane derivatives
Apparatus and methods for presentation of information relating to objects being addressed
Amine treatment in light olefin processing
Incontinence device and applicator
Subcutaneous injection set with improved cannula mounting arrangement
Method for indicating loaded firearm chamber
Catalyst for making polyurethanes
Integrated power device having a start-up structure
Holding device for boring head tools or the like
Organic light emitting display and method of manufacturing the same